Functional consequences of constitutively active α2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes

Biochemical and Biophysical Research Communications

Volumn 235, Issue 3, 1997, Pages 765-773

  Bétuing, Sandrine ^a   Valet, Philippe ^a   Lapalu, Sophie ^a   Peyroulan, Delphine ^a   Hickson, Gilles ^a   Daviaud, Danièle ^a   Lafontan, Max ^a   Saulnier Blache, Jean Sébastien ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROADIPOCYTE;

EID: 0031587962     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6887     Document Type: Article

References (30)

1. Parma J., Duprez L., Sande J. V., Paschke R., Tonacchera M., Dumont J., Vassart G. Mol. Cell. Endocrinol. 100:1994;159-162.
2. Lefkowitz R. J., Cotecchia S., Samama P., Costa T. Trends Pharmacol. Sci. 14:1993;303-307.
3. Samama P., Cotecchia S., Costa T., Lefkowitz R. J. J. Biol. Chem. 268:1993;4625-4636.
4. McEwan D., Milligan G. Mol. Pharmacol. 50:1996;1479-1486.
5. Samama P., Bond R. A., Rockman H. A., Milano C. A., Lefkowitz R. J. Proc. Natl. Acad. Sci. 94:1997;137-141.
6. Milano C. A., Allen L. F., Rockman H. A., Dolber P. C., McMinn T. R., Chien K. R., Johnson T. D., Bond R. A., Lefkowitz R. J. Science. 264:1994;582-586.
7. Lafontan M., Berlan M. J. Lip. Res. 34:1993;1057-1091.
8. Bylund D. B., Eikenberg D. C., Heibel J. P., Salomon S. Z., Lefkowitz R. J., Minneman K. P., Molinoff P. B., Ruffolo R. R., Trendelenburg U. Pharmacol. Rev. 46:1994;121-136.
9. Castan I., Devedjian J. C., Valet P., Paris H., Lafontan M. Fundam. Clin. Pharmacol. 9:1995;569-575.
10. Lafontan M., Berlan M. Endrocrine Rev. 16:1995;716-738.
11. Ren Q., Kurose H., Lefkowitz R. J., Cotecchia S. J. Biol. Chem. 268:1993;16483-16487.
12. Cornelius P., Macdougald O. A., Lane M. D. Annu. Rev. Nutr. 14:1994;99-129.
13. Bouloumié A., Planat V., Devedjian J.-C., Valet P., Saulnier-Blache J.-S., Record M., Lafontan M. J. Biol. Chem. 269:1994;30254-30259.
14. Bétuing S., Daviaud D., Valet P., Bouloumié A., Lafontan M., Saulnier-Blache J. Endocrinol. 137:1996;5220-5229.
15. Devedjian J. C., Esclapez F., Denis-Pouxviel C., Paris H. Eur. J. Pharmacol. 1994.
16. Green H., Kehinde O. Cell. 7:1976;105-113.
17. Saulnier-Blache J.-S., Carpene C., Langin D. Eur. J. Pharmacol. 171:1989;147-157.
18. McPherson G. A. J. Pharmacol. Methods. 14:1985;213-228.
19. Forest C., Doglio A., Riquier D., Ailhaud G. Exp. Cell Res. 168:1987;218-232.
20. Fredrickson G., Strålfors P., Nilsson N. Ö., Belfrage P. J. Biol. Chem. 256:1981;6311-6320.
21. Remaury A., Larrouy D., Daviaud D., Rouot B., Paris H. Biochem. J. 292:1993;283-288.
22. Homburger V., Brabet P., Audigier Y., Pantaloni C., Bockaert J., Rouot B. Molecular Pharmaclogy. 31:1987;313-319.
23. Seuwen K., Magnaldo I., Kobilka B. K., Caron M. G., Regan J. W., Lefkowitz R. J., Pouysségur J. Cell Regulation. 1:1990;445-451.
24. Allen L. F., Lefkowitz R. J., Caron M. G., Cotecchia S. Proc. Natl. Acad. Sci. USA. 88:1991;11354-11358.
25. Lee T. W., Cotecchia S., Milligan G. Biochem. J. 320:1996;79-86.
26. Kilgour e., Anderson N. G. FEBS Lett. 3:1993;271-274.
27. Hoffman B. B., Chang H., Dall'Aglio E., Reaven G. M. J. Clin. Invest. 78:1986;185-190.
28. Gasic S., Green A. Biochem. Pharmacol. 49:1995;785-790.
29. Moxham C. M., Hod Y., Malbon C. C. Science. 260:1993;991-995.
30. Gether U., Ballesteros J. A., Seifert R., Sanders-Bush E., Weinstein H., Kbilka B. K. J. Biol. Chem. 272:1997;2587-2590.